Study of the influence of nifedipine on the pharmacokinetics and pharmacodynamics of propranolol, metoprolol and atenolol.
The influence of chronic therapy with nifedipine on the pharmacokinetics of propranolol 80 mg twice daily, metoprolol 100 mg twice daily and atenolol 100 mg once daily was investigated in eight healthy volunteers. Nifedipine 10 mg three times daily did not affect the pharmacokinetics of metoprolol and atenolol whereas nifedipine shortened the time to peak plasma concentration for propranolol by about 1 h. Propranolol, metoprolol and atenolol provoked comparable decreases in heart rate measured at rest and during exercise. The beta-adrenoceptor blocking properties of propranolol, metoprolol and atenolol were not affected by concomitant therapy with nifedipine. The present study did not show significant pharmacokinetic and pharmacodynamic interactions between nifedipine and lipophilic beta-adrenoceptor blockers.
D000319:Adrenergic beta-Antagonists / Q000378:metabolism*; D000328:Adult; D001262:Atenolol / Q000378:metabolism / Q000494:pharmacology; D004347:Drug Interactions; D006801:Humans; D007700:Kinetics; D008297:Male; D008790:Metoprolol / Q000378:metabolism / Q000494:pharmacology; D009543:Nifedipine / Q000494:pharmacology*; D011433:Propranolol / Q000378:metabolism / Q000494:pharmacology
D000319:Adrenergic beta-Antagonists; D001262:Atenolol; D011433:Propranolol; D008790:Metoprolol; D009543:Nifedipine